Distribution and Drug-Resistance Analysis of Uropathogens in Urinary Tract Infections
Abstract
Background: Urinary tract infections (UTIs) are a major global health concern with increasing antimicrobial resistance. Regional data on pathogen distribution and resistance patterns are essential for guiding empirical therapy. This study aimed to investigate the distribution and antimicrobial resistance profiles of UTI pathogens in Shanghai, China, and identify risk factors associated with UTIs.
Methods: A retrospective analysis was conducted on urine culture records from 61,450 patients suspected of UTIs, collected between January 1 and December 31, 2023, from two general hospitals in Shanghai. Pathogen identification and antimicrobial susceptibility testing were performed according to CLSI guidelines (2021). Multivariable logistic regression was used to analyze risk factors for UTIs.
Results: Among 5671 confirmed UTI cases, Escherichia coli was the predominant pathogen (36.1%), followed by Enterococcus faecalis (11.2%) and Klebsiella pneumoniae (8.2%). E. coli exhibited high resistance to ampicillin (75.9%), levofloxacin (59.2%), and cefazolin (49.1%) but low resistance to carbapenems (1.0%). K. pneumoniae showed higher resistance rates, with the highest to ampicillin (97.3%) and levofloxacin (45.1%). Proteus spp. demonstrated significant resistance to ampicillin (66.7%) and fosfomycin (34.6%). Multivariable analysis identified female sex (OR = 1.55, 95% CI: 1.25-1.89), age > 60 years (OR = 2.60, 95% CI: 2.08-2.99), and hospitalization (OR = 2.49, 95% CI: 1.95-2.95) as…
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.